NEVVI Medicare utilization intelligence

← back

BEARDSLEY, ANDREWM.D. NPI 1881855948 Clinician

Internal Medicine · ASHEVILLE, NC

Specialty Internal Medicine — from billed Medicare claims
Trained WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 18 years since medical school (class of 2008, self-reported to CMS)
Location ASHEVILLE, NC · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 63 codes billed · 88,749 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
AMERICAN ONCOLOGY PARTNERS PA
2020–2026
MISSION COMMUNITY ANESTHESIOLOGY SPECIALISTS LLC
2019
MISSION HOSPITAL INC
2019

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2020-09

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
J0185 Injection, aprepitant, 1 mg
J9025 Injection, azacitidine, 1 mg
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J9299 Injection, nivolumab, 1 mg
J1437 Injection, ferric derisomaltose, 10 mg
J9267 Injection, paclitaxel, 1 mg
J9041 Injection, bortezomib, 0.1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J0897 Injection, denosumab, 1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J2469 Injection, palonosetron hcl, 25 mcg
36415 Insertion of needle into vein for collection of blood sample
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J2405 Injection, ondansetron hydrochloride, per 1 mg
J0640 Injection, leucovorin calcium, per 50 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
96413 Administration of chemotherapy into vein, 1 hour or less
J9190 Injection, fluorouracil, 500 mg
J9045 Injection, carboplatin, 50 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96375 Injection of additional new drug or substance into vein
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
Q5130 Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg
96372 Injection of drug or substance under skin or into muscle
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
96417 Administration of additional new drug or substance into vein, 1 hour or less
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
J3489 Injection, zoledronic acid, 1 mg
J1200 Injection, diphenhydramine hcl, up to 50 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96523 Irrigation of implanted venous access drug delivery device
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96415 Administration of chemotherapy into vein, each additional hour
81002 Urinalysis, manual test
96360 Infusion into a vein for hydration, 31-60 minutes
J7030 Infusion, normal saline solution , 1000 cc
J3490 Unclassified drugs
96411 Administration of additional new drug or substance into vein using push technique
85045 Red blood count, automated test
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96361 Infusion into a vein for hydration, each additional hour
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
78816 Nuclear medicine study whole body with ct scan
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
99195 Drawing of blood for a medical problem
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes
71260 Ct scan of chest with contrast
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.